DexCom (DXCM) is back in focus after Health Canada cleared its G7 sensor for use with the myLoop system powered by CamAPS FX ...

Health Canada has approved use of the Dexcom G7 continuous glucose monitoring system within the myLoop automated insulin ...

Glucose monitoring specialist Dexcom announced it received FDA clearance for its G7 15 Day continuous glucose monitoring (CGM) system for people 18 and older with type 1, type 2 and gestational ...

Dexcom G7 15 Day arrives in Canada in November with longer sensor wear and expanded insurance coverage. Here's what users ...

New data from Dexcom has demonstrated the benefit of its G7 continuous glucose monitor (CGM) in type 2 diabetes (TD2) patients not receiving insulin, suggesting a new standard of care (SoC) could be ...

Health Canada has approved the use of the Dexcom G7 Continuous Glucose Monitoring System with myLoop, powered by CamAPS FX, ...

Editor's note: This article has been updated with a comment from a Pharmsource spokesperson. Continuous glucose monitoring specialist Dexcom has identified two lots of Dexcom G7 sensors (1725204004 ...

With more than 10 years of pioneering CGM market leadership in AID integration, Dexcom is the most studied CGM brand with AID capabilities and the clear choice for powering AID systems 3,4 The ...

Dexcom reaffirmed its 2025 revenue guidance of $4.6 billion, representing 14% growth. The company also maintained its operating margin and adjusted EBITDA margin guidance at approximately 21% and 30%, ...

After months of international availability, the Dexcom G7 constant glucose monitor received its FDA clearance to distribute in the US. Ahead of the wide rollout, we got to go hands-on with a demo ...

The G7 system is now available in the U.K., Ireland, Germany, Austria and Hong Kong. Dexcom said it plans to reach outlets in South Africa and New Zealand in the weeks ahead and additional countries ...